Logo image of CHE

CHEMED CORP (CHE) Stock Fundamental Analysis

NYSE:CHE - New York Stock Exchange, Inc. - US16359R1032 - Common Stock - Currency: USD

574.69  -6.79 (-1.17%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CHE. CHE was compared to 102 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CHE a very profitable company, without any liquidiy or solvency issues. CHE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CHE was profitable.
CHE had a positive operating cash flow in the past year.
Each year in the past 5 years CHE has been profitable.
Each year in the past 5 years CHE had a positive operating cash flow.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of CHE (17.88%) is better than 98.04% of its industry peers.
The Return On Equity of CHE (26.13%) is better than 91.18% of its industry peers.
The Return On Invested Capital of CHE (22.08%) is better than 94.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 9.53%.
The 3 year average ROIC (21.96%) for CHE is below the current ROIC(22.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.88%
ROE 26.13%
ROIC 22.08%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

The Profit Margin of CHE (12.40%) is better than 97.06% of its industry peers.
In the last couple of years the Profit Margin of CHE has grown nicely.
CHE's Operating Margin of 16.62% is amongst the best of the industry. CHE outperforms 93.14% of its industry peers.
In the last couple of years the Operating Margin of CHE has grown nicely.
CHE has a better Gross Margin (34.82%) than 63.73% of its industry peers.
CHE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.62%
PM (TTM) 12.4%
GM 34.82%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

CHE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CHE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHE has less shares outstanding
CHE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 14.01 indicates that CHE is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 14.01, CHE belongs to the best of the industry, outperforming 95.10% of the companies in the same industry.
CHE has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
CHE has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. CHE outperforms 92.16% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CHE is not too dependend on debt financing.
The Debt to Equity ratio of CHE (0.00) is better than 87.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.01
ROIC/WACC2.43
WACC9.1%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.73 indicates that CHE should not have too much problems paying its short term obligations.
CHE's Current ratio of 1.73 is in line compared to the rest of the industry. CHE outperforms 59.80% of its industry peers.
CHE has a Quick Ratio of 1.70. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
CHE has a better Quick ratio (1.70) than 63.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.7
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

CHE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.97%.
Measured over the past years, CHE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.64% on average per year.
Looking at the last year, CHE shows a quite strong growth in Revenue. The Revenue has grown by 8.52% in the last year.
The Revenue has been growing slightly by 4.63% on average over the past years.
EPS 1Y (TTM)7.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%8.27%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%9.79%

3.2 Future

Based on estimates for the next years, CHE will show a small growth in Earnings Per Share. The EPS will grow by 7.90% on average per year.
Based on estimates for the next years, CHE will show a small growth in Revenue. The Revenue will grow by 6.76% on average per year.
EPS Next Y10.34%
EPS Next 2Y9.62%
EPS Next 3Y7.9%
EPS Next 5YN/A
Revenue Next Year8.61%
Revenue Next 2Y7.34%
Revenue Next 3Y6.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.38 indicates a rather expensive valuation of CHE.
Based on the Price/Earnings ratio, CHE is valued a bit cheaper than 62.75% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.60, CHE is valued at the same level.
CHE is valuated rather expensively with a Price/Forward Earnings ratio of 20.67.
The rest of the industry has a similar Price/Forward Earnings ratio as CHE.
CHE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.43.
Industry RankSector Rank
PE 24.38
Fwd PE 20.67
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CHE.
The rest of the industry has a similar Price/Free Cash Flow ratio as CHE.
Industry RankSector Rank
P/FCF 26.69
EV/EBITDA 17.48
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)2.36
PEG (5Y)2.29
EPS Next 2Y9.62%
EPS Next 3Y7.9%

5

5. Dividend

5.1 Amount

CHE has a yearly dividend return of 0.35%, which is pretty low.
CHE's Dividend Yield is a higher than the industry average which is at 2.46.
Compared to an average S&P500 Dividend Yield of 2.36, CHE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.35%

5.2 History

The dividend of CHE is nicely growing with an annual growth rate of 8.02%!
CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHE pays out 9.19% of its income as dividend. This is a sustainable payout ratio.
CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.19%
EPS Next 2Y9.62%
EPS Next 3Y7.9%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

CHEMED CORP

NYSE:CHE (5/21/2025, 10:57:31 AM)

574.69

-6.79 (-1.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-22 2025-07-22/amc
Inst Owners94.93%
Inst Owner Change0.72%
Ins Owners1.59%
Ins Owner Change0.1%
Market Cap8.41B
Analysts85.71
Price Target690.88 (20.22%)
Short Float %1.61%
Short Ratio1.71
Dividend
Industry RankSector Rank
Dividend Yield 0.35%
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP9.19%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-24 2025-02-24 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.09%
Min EPS beat(2)-0.31%
Max EPS beat(2)0.5%
EPS beat(4)1
Avg EPS beat(4)-1.51%
Min EPS beat(4)-3.17%
Max EPS beat(4)0.5%
EPS beat(8)3
Avg EPS beat(8)-1.04%
EPS beat(12)6
Avg EPS beat(12)-0.62%
EPS beat(16)10
Avg EPS beat(16)1.17%
Revenue beat(2)0
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.38%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.02%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.19%
Revenue beat(8)1
Avg Revenue beat(8)-1.12%
Revenue beat(12)2
Avg Revenue beat(12)-1.02%
Revenue beat(16)4
Avg Revenue beat(16)-0.8%
PT rev (1m)-1.48%
PT rev (3m)2.06%
EPS NQ rev (1m)1.48%
EPS NQ rev (3m)3.09%
EPS NY rev (1m)0.36%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)0.62%
Revenue NQ rev (3m)1.54%
Revenue NY rev (1m)0.45%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE 24.38
Fwd PE 20.67
P/S 3.38
P/FCF 26.69
P/OCF 22.99
P/B 7.11
P/tB 19.79
EV/EBITDA 17.48
EPS(TTM)23.57
EY4.1%
EPS(NY)27.81
Fwd EY4.84%
FCF(TTM)21.53
FCFY3.75%
OCF(TTM)25
OCFY4.35%
SpS170.13
BVpS80.78
TBVpS29.04
PEG (NY)2.36
PEG (5Y)2.29
Profitability
Industry RankSector Rank
ROA 17.88%
ROE 26.13%
ROCE 28.8%
ROIC 22.08%
ROICexc 25.12%
ROICexgc 62.73%
OM 16.62%
PM (TTM) 12.4%
GM 34.82%
FCFM 12.66%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexcg growth 3Y-5.61%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 80.07%
Cap/Sales 2.03%
Interest Coverage 250
Cash Conversion 76.69%
Profit Quality 102.04%
Current Ratio 1.73
Quick Ratio 1.7
Altman-Z 14.01
F-Score7
WACC9.1%
ROIC/WACC2.43
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)7.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%8.27%
EPS Next Y10.34%
EPS Next 2Y9.62%
EPS Next 3Y7.9%
EPS Next 5YN/A
Revenue 1Y (TTM)8.52%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%9.79%
Revenue Next Year8.61%
Revenue Next 2Y7.34%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
EBIT growth 1Y10.75%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year28.98%
EBIT Next 3Y12.84%
EBIT Next 5YN/A
FCF growth 1Y51.76%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y35.8%
OCF growth 3Y10.6%
OCF growth 5Y6.75%